fluorides has been researched along with Osteoporosis, Postmenopausal in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 76 (71.70) | 18.2507 |
2000's | 26 (24.53) | 29.6817 |
2010's | 3 (2.83) | 24.3611 |
2020's | 1 (0.94) | 2.80 |
Authors | Studies |
---|---|
El-Nassery, N; Fouad, M; Hassan, ES; Kamal, WM; Kotb, A; Maged, AM | 1 |
Alahmari, AD; Ayed, MS; Diab, HM; Divakar, DD; Shafiq, SS | 1 |
Bolland, M; Callon, K; Cundy, T; Dray, M; Gamble, G; Garg, S; Grey, A; Horne, A; Purvis, L; Reid, IR | 1 |
Kang, L; Lv, YG; Wu, G | 1 |
Bilezikian, JP; Rubin, MR | 2 |
Ringe, JD; Setnikar, I | 1 |
Oral, B; Ozbaşar, D | 1 |
Meyer, G | 1 |
Felsenberg, D; Glüer, CC; Mühlenbacher, D; Nickelsen, T; Pavo, I; Payer, J; Quail, D; Reginster, JY; Resch, H; Schmitt, H; Stepan, J | 1 |
Keck, E | 1 |
Dorst, A; Faber, H; Kipshoven, C; Ringe, JD; Rovati, LC; Setnikar, I | 1 |
McGregor, DO; Palmer, SC; Strippoli, GF | 1 |
Khan, A; Khan, AW | 1 |
Ames, R; Clearwater, J; Cundy, T; Evans, MC; Gamble, GD; Grey, AB; Horne, A; King, A; Orr-Walker, BJ; Reid, IR; Wu, F | 1 |
Bors, K | 1 |
Buhari, AM; Cauley, JA; Murphy, PA; Riley, TJ | 1 |
Gamble, CL | 1 |
Hermann, A; Mosekilde, L; Rungby, J | 1 |
Geidel, H | 1 |
Leidig-Bruckner, G; Ziegler, R | 1 |
Brizendine, E; Dunipace, A; Farley, S; Jackson, R; Katz, B; Kelly, S; Li, Y; Noblitt, T; Stookey, G; Zhang, W | 1 |
Alhava, E; Honkanen, R; Kröger, H; Saarikoski, S; Tuppurainen, M | 1 |
Bottermann, P | 1 |
Burckhardt, P; Lamy, O; Thiébaud, D | 1 |
Hanhijärvi, H; Hyvönen, PM; Karhi, T; Kosma, VM; Liimola-Luoma, L | 1 |
Grioli, MF; Marsico, S; Pizzo, A; Scriva, D; Sodo, G | 1 |
Baran, DT | 1 |
Burckhardt, P; Eckert, P; Gobelet, C; Jacquet, AF; Melchior, J; Schnyder, P; Thiébaud, D | 1 |
Baylink, D; Bettica, P; Farley, S; Libanati, C; Resch, H; Tabuenca, M; Talbot, J; Tritthart, W | 1 |
Adams-Huet, B; Boyd, P; Breslau, NA; Haynes, S; Heard-Sakhaee, A; Herzog, J; Pak, CY; Peterson, RD; Piziak, V; Poindexter, JR; Reisch, JS; Sakhaee, K | 1 |
Affinito, P; Di Carlo, C; Napolitano, V; Nappi, C; Petrillo, G; Primizia, M; Tremolaterra, F | 1 |
Clairet, D; Eisinger, J | 1 |
Dambacher, MA; Felder, M | 1 |
Ringe, JD | 5 |
Cristallini, S; Donatelli, C; Filipponi, P; Gregorio, F; Pedetti, M | 1 |
Daly, PA | 1 |
Melton, LJ; O'Fallon, WM; Riggs, BL | 1 |
Bellantoni, MF | 1 |
Krapf, R; Villiger, PM | 1 |
Bowman, MA; Spangler, JG | 1 |
Battmann, A; Baylink, DJ; Farley, S; Fischer, M; Libanati, CR; Ludy, D; Resch, H | 1 |
Affinito, P; Morgera, R; Nappi, C; Palomba, S; Pellicano, M; Sorrentino, C | 1 |
Body, JJ; Devogelaer, JP; Kaufman, JM; Raeman, F; Reginster, JY; Rozenberg, S; Westhovens, R | 1 |
Seeman, E | 1 |
Lane, JM | 1 |
Eastell, R | 1 |
Kruse, HP | 1 |
Kocián, J | 2 |
Collette, J; Giacovelli, G; Gosset, C; Meurmans, L; Minne, HW; Reginster, JY; Rovati, LC; Setnikar, I; Taquet, AN; Zegels, B | 1 |
Appelboom, T; Avouac, B; Barry, S; Briancon, D; Evreux, JC; Loeb, G; Marchandise, X; Meunier, PJ; Netter, P; Reginster, JY; Rouillon, A; Sebert, JL | 1 |
Benevolenskaya, L; Cannata, J; Dequeker, J; Dohenhof, C; Falch, JA; Felsenberg, D; Lunt, M; Masaryk, P; O'Neill, T; Pols, HA; Poor, G; Reeve, J; Reid, DM; Scheidt-Nave, C; Silman, AJ; Weber, K | 1 |
Ziegler, R | 2 |
Netelenbos, C | 1 |
Lesser, GT | 1 |
Weil, VP | 1 |
Kremling, E; Martini, F; Sell, S | 1 |
Allolio, B; Lehmann, R | 1 |
Cöster, A; Kipshoven, C; Ringe, JD; Umbach, R | 1 |
Bocanera, R; Masoni, A; Morosano, M; Pera, L; Puche, RC; Rigalli, A; Tozzini, R | 1 |
Alloatti, R; Puche, RC; Rigalli, A | 1 |
Mundy, GR | 1 |
Gosset, C; Halkin, V; Henrotin, Y; Reginster, JY | 1 |
Agnusdei, D; Gennari, C; Kicovic, PM; Reginster, JY | 1 |
Reid, IR | 1 |
Wimalawansa, SJ | 1 |
Haguenauer, D; Shea, B; Tugwell, P; Welch, V; Wells, G | 1 |
Adachi, JD; Haguenauer, D; Shea, B; Tugwell, P; Welch, V; Wells, G | 1 |
Mosekilde, L | 1 |
Reginster, JY; Rovati, LC; Setnikar, I | 1 |
Pfeilschifter, J | 2 |
Meunier, PJ | 2 |
Blake, GM; Fogelman, I; Park-Holohan, SJ | 1 |
Duque, G | 1 |
Buchman, A; DeSantis, A | 1 |
Sartoris, DJ; Theodorou, DJ; Theodorou, SJ | 1 |
Sane, T | 1 |
Ebeling, PR; Peterson, JM; Riggs, BL | 1 |
Bardin, C; Brouard, A; Kuntz, D; Lioté, F; Liou, A; Terrier, JL | 1 |
Hesch, RD; Rittinghaus, EF | 1 |
Bocanera, R; Dip, O; Pereyra, JL; Poudes, G; Puche, RC; Rigalli, A; Roberti, A; Tozzini, R; Trumper, L | 1 |
Schiff, I; Walsh, BW | 1 |
Pak, CY; Sakhaee, K | 1 |
Inkovaara, JA | 1 |
Gerber, NJ; Rey, B | 1 |
Baylink, DJ; Gruber, HE | 1 |
Christiansen, C; Riis, P | 1 |
Berry, H; Pitt, P | 1 |
Schapira, D | 1 |
Minne, HW | 1 |
Trachtenbarg, DE | 1 |
Chapuy, MC; Delmas, PD; Duboeuf, F; Dupuis, J; Meunier, PJ | 1 |
Baylink, DJ; Farley, SM; Libanati, CR; Mariano-Menez, MR; Schulz, EE; Tudtud-Hans, LA | 1 |
Brabant, G; Harms, H; Hesch, RD; Rittinghaus, EF | 1 |
Alhava, E | 1 |
Bockman, RS; Weinerman, SA | 1 |
48 review(s) available for fluorides and Osteoporosis, Postmenopausal
Article | Year |
---|---|
New anabolic therapies in osteoporosis.
Topics: Alendronate; Bone and Bones; Bone Resorption; Drug Therapy, Combination; Female; Fluorides; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Osteogenesis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium | 2002 |
New anabolic therapies in osteoporosis.
Topics: Aged; Bone and Bones; Bone Density; Female; Fluorides; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor I; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium | 2003 |
Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
Topics: Bone Density; Calcitonin; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diphosphonates; Female; Femur Neck; Fluorides; Fractures, Spontaneous; Hormone Replacement Therapy; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lumbar Vertebrae; Male; Osteoporosis; Osteoporosis, Postmenopausal; Postoperative Complications; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Steroids; Treatment Outcome; Vitamin D | 2005 |
Anabolic agents: a new chapter in the management of osteoporosis.
Topics: Anabolic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Fluorides; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organometallic Compounds; Osteoporosis, Postmenopausal; Teriparatide; Thiophenes | 2006 |
[Up-to-date treatments for osteoporosis].
Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D | 2006 |
Osteoporosis: drug and nondrug therapies for the patient at risk.
Topics: Calcitonin; Calcium, Dietary; Estrogen Replacement Therapy; Exercise Therapy; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Risk Factors | 1995 |
Epidemiology of osteoporosis. Implications for drug therapy.
Topics: Calcium, Dietary; Colles' Fracture; Diphosphonates; Estrogen Replacement Therapy; Exercise; Female; Fluorides; Hip Fractures; Humans; Life Style; Osteoporosis, Postmenopausal; Risk Assessment; Spinal Fractures; Vitamin D | 1995 |
[Therapy of osteoporosis].
Topics: Adult; Aged; Calcitonin; Calcium, Dietary; Combined Modality Therapy; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1995 |
[Modern treatment of primary osteoporosis].
Topics: Adult; Aged; Calcitonin; Cholecalciferol; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal | 1994 |
Osteoporosis: monitoring techniques and alternate therapies. Calcitonin, fluoride, bisphosphonates, vitamin D.
Topics: Biomarkers; Bone Density; Calcitonin; Diagnosis, Differential; Diagnostic Imaging; Diphosphonates; Female; Fluorides; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1994 |
Office management of osteoporosis: a guide for the primary care provider.
Topics: Adolescent; Adult; Aged; Calcitonin; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic Acid; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Primary Health Care; Risk Factors; Treatment Outcome; Vitamin D | 1995 |
Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.
Topics: Bone Density; Bone Resorption; Computer Simulation; Controlled Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Spinal Fractures; Spine | 1996 |
Osteoporosis prevention and treatment.
Topics: Absorptiometry, Photon; Alendronate; Calcitonin; Diphosphonates; Exercise; Female; Fluorides; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1996 |
[Osteoporosis of the lumbar spine].
Topics: Adult; Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Exercise; Female; Fluorides; Glucocorticoids; Humans; Life Style; Lumbar Vertebrae; Middle Aged; Osteomalacia; Osteoporosis; Osteoporosis, Postmenopausal; Vitamin D | 1996 |
Osteoporosis in women.
Topics: Adult; Aged; Aging; Bone Density; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Exercise; Female; Fluorides; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1997 |
[Postmenopausal osteoporosis: therapeutic approaches].
Topics: Anabolic Agents; Bone Remodeling; Calcitonin; Calcitriol; Calcium; Diphosphonates; Estrogens; Female; Fluorides; Humans; Isoflavones; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Progestins | 1997 |
Osteoporosis: trials and tribulations.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Calcitonin; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic Acid; Female; Fluorides; Fractures, Bone; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Vitamin D | 1997 |
Osteoporosis. Medical prevention and treatment.
Topics: Adolescent; Adult; Aged; Bone Density; Calcitonin; Calcium; Child; Child, Preschool; Diphosphonates; Estrogens; Female; Fluorides; Humans; Infant; Infant, Newborn; Male; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 1997 |
[Value of fluoride therapy in osteoporosis].
Topics: Bone Density; Female; Fluorides; Fractures, Spontaneous; Humans; Male; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Spinal Fractures | 1997 |
Treatment of postmenopausal osteoporosis.
Topics: Calcitonin; Calcium; Diphosphonates; Drug Evaluation; Estrogen Replacement Therapy; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1998 |
[Halved fracture risk through 10% bone increase--an illusion in the therapy of osteoporosis?].
Topics: Aged; Bone Density; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Risk Factors | 1998 |
[Drug treatment of osteoporosis (in the woman)].
Topics: Aged; Aged, 80 and over; Anabolic Agents; Bone Density; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 1998 |
Osteoporosis: intervention options.
Topics: Calcitonin; Calcium; Diphosphonates; Estrogen Antagonists; Estrogens; Female; Fluorides; Hormone Replacement Therapy; Humans; Osteoporosis, Postmenopausal; Parathyroid Hormone; Vitamin D | 1998 |
[Osteoporosis therapy. A pluralistic approach].
Topics: Calcitonin; Calcium, Dietary; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Spontaneous; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Vitamin D | 1998 |
What can we learn from bone biology for the treatment for osteoporosis?
Topics: Aged; Aging; Bone and Bones; Bone Resorption; Female; Fluorides; Growth Substances; Humans; Middle Aged; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Parathyroid Hormone | 1999 |
Treatment of osteoporosis: role of bone-forming agents.
Topics: Anabolic Agents; Animals; Bone and Bones; Bone Density; Bone Remodeling; Female; Fluorides; Growth Hormone; Humans; Male; Osteoporosis, Postmenopausal; Parathyroid Hormone; Somatomedins; Strontium | 1999 |
Pharmacological management of osteoporosis in postmenopausal women: a comparative review.
Topics: Benzothiadiazines; Calcitonin; Calcium; Diphosphonates; Diuretics; Female; Fluorides; Hormone Replacement Therapy; Humans; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Vitamin D | 1999 |
Prevention and treatment of osteoporosis: efficacy of combination of hormone replacement therapy with other antiresorptive agents.
Topics: Bone Density; Diphosphonates; Drug Therapy, Combination; Fluorides; Hormone Replacement Therapy; Humans; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Fluoride for treating postmenopausal osteoporosis.
Topics: Bone Density; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates; Randomized Controlled Trials as Topic; Sodium Fluoride | 2000 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Rats; Retrospective Studies; Sodium Fluoride; Spinal Fractures; Strontium; Time Factors | 2000 |
Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.
Topics: Aged; Bone Density; Calcium; Case-Control Studies; Delayed-Action Preparations; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Vitamin D | 2000 |
Anabolic agents for treating postmenopausal osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Female; Fluorides; Fractures, Spontaneous; Growth Hormone; Humans; Insulin-Like Growth Factor I; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Simvastatin; Thiophenes | 2001 |
Anabolic agents to treat osteoporosis in older people: is there still place for fluoride? Fluoride for treating postmenopausal osteoporosis.
Topics: Aged; Bone Density; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Spinal Fractures | 2001 |
Current and emerging therapies in osteoporosis.
Topics: Absorptiometry, Photon; Aging; Calcitonin; Calcium; Clinical Trials as Topic; Diphosphonates; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Practice Guidelines as Topic | 2002 |
Treatment of osteoporosis: current status and recent advances.
Topics: Benzothiadiazines; Calcitonin; Calcium; Diphosphonates; Diuretics; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Selective Estrogen Receptor Modulators; Sodium Chloride Symporter Inhibitors; Vitamin D | 2002 |
[What is new in the treatment of osteoporosis?].
Topics: Aged; Benzothiadiazines; Diuretics; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Sodium Chloride Symporter Inhibitors | 1991 |
[Conclusive evaluation of osteoporosis therapy with fluorides].
Topics: Bone Density; Dose-Response Relationship, Drug; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Sodium Fluoride | 1991 |
Menopause: advanced management strategies.
Topics: Calcium; Estrogen Replacement Therapy; Etidronic Acid; Female; Fluorides; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal | 1991 |
Is fluoride treatment justified today?
Topics: Female; Fluorides; Fractures, Bone; Humans; Osteoporosis; Osteoporosis, Postmenopausal | 1991 |
[Therapy of osteoporosis with fluorides and calcitonins].
Topics: Aged; Bone Density; Calcitonin; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal | 1991 |
[Postmenopausal osteoporosis: are there alternatives to estrogen/gestagen substitution?].
Topics: Adult; Anabolic Agents; Calcitonin; Calcium; Calcium, Dietary; Diphosphonates; Exercise; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 1991 |
The effects of fluoride on bone.
Topics: Aged; Animals; Bone and Bones; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Rabbits; Rats; Spinal Fractures | 1991 |
[Consensus Development Conference. Prevention and treatment of osteoporosis].
Topics: Absorptiometry, Photon; Anabolic Agents; Bone Density; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Risk Factors | 1991 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |
Prevention and treatment of osteoporosis.
Topics: Calcitonin; Calcium, Dietary; Estrogen Replacement Therapy; Exercise; Female; Fluorides; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1990 |
[Osteoporosis as a cause of pathological fractures].
Topics: Aged; Calcium; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Spontaneous; Hip Fractures; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Spinal Diseases | 1990 |
[What is reliable in therapy of osteoporosis?].
Topics: Aged; Anabolic Agents; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone | 1990 |
Medical therapy of osteoporosis.
Topics: Benzothiadiazines; Calcitonin; Diphosphonates; Diuretics; Estradiol Congeners; Female; Fluorides; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Sodium Chloride Symporter Inhibitors; Vitamin D | 1990 |
23 trial(s) available for fluorides and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Effect of laser acupuncture on pain and density of bone in osteoporotic postmenopausal women: a randomized controlled trial.
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Calcium, Dietary; Female; Fluorides; Humans; Lasers; Osteoporosis, Postmenopausal; Pain; Postmenopause | 2023 |
Low-dose fluoride in postmenopausal women: a randomized controlled trial.
Topics: Aged; Bone Density; Bone Remodeling; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause | 2013 |
Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study.
Topics: Aged; Analgesics; Back Pain; Bone and Bones; Bone Density; Calcium; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Pilot Projects; Spinal Fractures; Treatment Outcome | 2002 |
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Topics: Adult; Aged; Analysis of Variance; Anthropometry; Bone Density; Bone Diseases, Metabolic; Double-Blind Method; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Calcaneus; Calcium; Dietary Supplements; Drug Therapy, Combination; Etidronic Acid; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Pain; Phosphates; Pilot Projects; Range of Motion, Articular; Spinal Fractures; Treatment Outcome; Ultrasonography; Vitamin D | 2005 |
Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
Topics: Aged; Biopsy; Bone Density; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Fluorides; Follow-Up Studies; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Treatment Outcome | 2007 |
The effect of fluoride therapy on blood chemistry parameters in osteoporotic females.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bilirubin; Blood Chemical Analysis; Bone and Bones; Calcium Carbonate; Chlorides; Drug Therapy, Combination; Female; Fluorides; gamma-Glutamyltransferase; Humans; L-Lactate Dehydrogenase; Liver; Lymphocytes; Middle Aged; Osteoporosis, Postmenopausal; Serum Albumin; Serum Globulins; Sister Chromatid Exchange; Sodium; Water | 1994 |
Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Density; Diphosphonates; Female; Femur Neck; Fluorides; Follow-Up Studies; Humans; Infusions, Intravenous; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Radius; Time Factors; Treatment Outcome | 1994 |
Pharmacokinetic profile of a new fluoride preparation: sustained-release monofluorophosphate.
Topics: Aged; Analysis of Variance; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Female; Fluorides; Humans; Ion-Selective Electrodes; Middle Aged; Osteoporosis, Postmenopausal; Phosphates | 1994 |
Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Topics: Aged; Aged, 80 and over; Bone Density; Citrates; Citric Acid; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride; Spinal Fractures | 1994 |
A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Female; Fluorides; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphates | 1993 |
[The effect of different "coherent"-type therapeutic plans on bone mineral density and on the incidence of vertebral fractures in advanced osteoporosis].
Topics: Adult; Aged; Analysis of Variance; Bone Density; Calcitonin; Calcium; Cholecalciferol; Drug Therapy, Combination; Female; Fluorides; Fractures, Spontaneous; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal; Regression Analysis; Spinal Fractures | 1993 |
Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: comparison with plain monofluorophosphate.
Topics: Aged; Delayed-Action Preparations; Double-Blind Method; Female; Fluorides; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phosphates | 1997 |
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Topics: Aged; Analysis of Variance; Bone Density; Calcium Carbonate; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Radiography; Spinal Fractures; Thoracic Vertebrae | 1998 |
Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Topics: Aged; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Ergocalciferols; Female; Fluorides; Fractures, Spontaneous; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Prospective Studies; Sodium Fluoride; Spinal Fractures; Time Factors | 1998 |
Effects of menstrual history and use of medications on bone mineral density: the EVOS Study.
Topics: Absorptiometry, Photon; Age Factors; Aged; Anabolic Agents; Bone Density; Calcitonin; Calcium, Dietary; Contraceptives, Oral; Europe; Female; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Male; Menstruation; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Sex Factors; Vitamin D | 1998 |
Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Topics: Aged; Body Height; Bone Density; Calcium; Dose-Response Relationship, Drug; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Prospective Studies; Spinal Fractures | 1999 |
In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
Topics: Bone Density; Female; Fluorides; Fluorides, Topical; Fluorine; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Time Factors | 1999 |
Measurement of total and diffusible serum fluoride.
Topics: Aged; Blood Proteins; Diffusion; Electrodes; Fasting; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Protein Binding; Sensitivity and Specificity; Sodium Fluoride | 1999 |
Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.
Topics: Absorptiometry, Photon; Aged; Anabolic Agents; Bone Density; Double-Blind Method; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Dropouts; Pelvic Bones | 1999 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Rats; Retrospective Studies; Sodium Fluoride; Spinal Fractures; Strontium; Time Factors | 2000 |
Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Topics: Aged; Biological Availability; Calcium Carbonate; Drug Combinations; Drug Evaluation; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Sodium Fluoride; Tablets, Enteric-Coated | 1992 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |
37 other study(ies) available for fluorides and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Assessing periapical dental radiographs as a screening parameter for early indications of osteoporosis in postmenopausal periodontal patients and root surface evaluation using spectrochemical analysis.
Topics: Aged; Bone Density; Calcium; Chronic Periodontitis; Comorbidity; Dental Plaque Index; Female; Fluorides; Gingival Pocket; Humans; Magnesium; Mass Screening; Middle Aged; Osteoporosis, Postmenopausal; Periodontal Index; Phosphorus; Postmenopause; Potassium; Radiography, Dental; Saudi Arabia; Spectrum Analysis; Tooth Root | 2018 |
Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
Topics: Aged; Animals; Bone Density; Bone Resorption; CD4-Positive T-Lymphocytes; Estrogen Receptor beta; Estrogens; Female; Fluorides; Fluorosis, Dental; Gene Silencing; Humans; Interferon-gamma; Mice; Mice, Inbred C57BL; Middle Aged; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Signal Transduction; Stem Cells; X-Ray Microtomography | 2016 |
Influence of NaMFP therapy on plasma leptin concentration in postmenopausal women.
Topics: Body Mass Index; Female; Fluorides; Humans; Leptin; Middle Aged; Obesity; Osteoporosis, Postmenopausal; Phosphates | 2002 |
[Critical appraisal of a meta-analysis on the effects of hormone replacement therapy on non-vertebral fractures and suggestions to increase the transparency of meta-analyses].
Topics: Aged; Calcium; Databases, Factual; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Bone; Humans; Meta-Analysis as Topic; Middle Aged; Osteoporosis, Postmenopausal; Vitamin D | 2002 |
[Therapy of postmenopausal osteoporosis].
Topics: Activities of Daily Living; Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Antagonists; Estrogens; Exercise; Female; Fluorides; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D; Walking | 2003 |
Effects of fluoridated drinking water on bone mass and fractures: the study of osteoporotic fractures.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Calcaneus; Cohort Studies; Female; Fluoridation; Fluorides; Follow-Up Studies; Fractures, Bone; Hip Joint; Humans; Incidence; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Prevalence; Radius; Reproducibility of Results; Risk Factors; Time Factors; White People | 1995 |
[Therapeutic concepts in the treatment of postmenopausal osteoporosis].
Topics: Aged; Calcium; Cholecalciferol; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Spontaneous; Humans; Middle Aged; Osteoporosis, Postmenopausal | 1994 |
The effect of fluoridated drinking water on axial bone mineral density--a population-based study.
Topics: Absorptiometry, Photon; Aged; Bone Density; Cohort Studies; Female; Femur Neck; Fluoridation; Fluorides; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prevalence; Reproducibility of Results; Spine | 1994 |
[The treatment of established osteoporosis].
Topics: Adult; Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Infant; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Vitamin D | 1995 |
The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat.
Topics: Animals; Body Weight; Bone Density; Calcium; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Female; Femoral Fractures; Femur; Fluorides; Fracture Healing; Humans; Injections, Subcutaneous; Magnesium; Osteocalcin; Osteoporosis, Postmenopausal; Phosphorus; Rats; Rats, Sprague-Dawley | 1994 |
[Postmenopausal osteoporosis. Current therapy protocols].
Topics: Adult; Aged; Calcitonin; Calcium, Dietary; Estrogens; Female; Fluorides; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Physical Exertion; Progestins | 1994 |
Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study.
Topics: Aged; Bone Density; Etidronic Acid; Female; Fluorides; Humans; Magnesium; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Silicon | 1993 |
[Osteoporosis therapy, current status].
Topics: Aged; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Physical Therapy Modalities; Vitamin D | 1994 |
[Differential therapy of osteoporosis].
Topics: Aged; Calcium; Calcium, Dietary; Estrogen Replacement Therapy; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Physical Therapy Modalities; Risk Factors | 1993 |
Prevention and treatment of postmenopausal osteoporosis. National Consensus of the "Belgian Bone Club", November 1996.
Topics: Anabolic Agents; Belgium; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Hormones; Humans; Osteoporosis, Postmenopausal; Vitamin D | 1997 |
[Fluorides and bones].
Topics: Bone and Bones; Female; Fluorides; Humans; Osteoporosis, Postmenopausal | 1997 |
Fluoride for the treatment of osteoporosis.
Topics: Calcium; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates | 1999 |
Fluoride for the treatment of osteoporosis.
Topics: Bone Density; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates; Time Factors | 1999 |
Bilateral atraumatic avulsion fracture of the calcaneal tubercle in osteomalacia during fluoride therapy--a case report.
Topics: Achilles Tendon; Calcaneus; Female; Fluorides; Fractures, Spontaneous; Humans; Middle Aged; Osteomalacia; Osteoporosis, Postmenopausal; Phosphates; Radiography; Rupture, Spontaneous | 1999 |
Fluoride and bone: a second look. No use in osteoporosis.
Topics: Aged; Calcium; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Ergocalciferols; Female; Fluorides; Fractures, Spontaneous; France; Humans; Middle Aged; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome | 1998 |
[Renaissance of fluorides and calcium in the treatment of osteoporosis].
Topics: Calcium; Female; Fluorides; Humans; Osteoporosis, Postmenopausal | 1999 |
[The role of fluorides in the treatment of postmenopausal osteoporosis].
Topics: Aged; Body Mass Index; Bone and Bones; Evidence-Based Medicine; Female; Fluorides; Humans; Meta-Analysis as Topic; Middle Aged; Osteoporosis, Postmenopausal; Practice Guidelines as Topic | 2001 |
[Fluorides and bisphosphonates in the treatment of osteoporosis].
Topics: Aged; Bone Density; Bone Resorption; Calcium, Dietary; Clinical Trials as Topic; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fluorides; Humans; Middle Aged; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Pilot Projects; Risedronic Acid; Spinal Fractures; Time Factors; Vitamin D | 2001 |
Correct regimen of fluoride and calcium reduces the risk of vertebral fractures in postmenopausal osteoporosis.
Topics: Calcium; Female; Fluorides; Humans; Meta-Analysis as Topic; Osteoporosis, Postmenopausal; Spinal Fractures | 2001 |
[Risk-adapted therapy of osteoporosis. Preventing fractures].
Topics: Absorptiometry, Photon; Aged; Calcium, Dietary; Cholecalciferol; Diphosphonates; Exercise; Female; Fluorides; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Assessment | 2001 |
Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Topics: Aged; Area Under Curve; Bone and Bones; Bone Remodeling; Chromium Radioisotopes; Edetic Acid; Estrogen Replacement Therapy; Female; Fluorides; Fluorine Radioisotopes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Radionuclide Imaging; Radiopharmaceuticals; Serum Albumin, Radio-Iodinated; Technetium Tc 99m Medronate | 2002 |
[Rational and cost effective osteoporosis prevention and therapy].
Topics: Aged; Cost-Benefit Analysis; Diphosphonates; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2002 |
Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Diseases, Metabolic; Child; Enzyme-Linked Immunosorbent Assay; Female; Fluorides; Humans; Male; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptide Fragments; Procollagen; Radioimmunoassay; Regression Analysis | 1992 |
Estimation of bone turnover in climacteric women by the whole body retention of fluoride.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Climacteric; Female; Fluorides; Humans; Hydroxyproline; Isoenzymes; Osteoporosis, Postmenopausal; Radionuclide Imaging; Technetium Tc 99m Medronate | 1991 |
Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.
Topics: Aged; Biological Availability; Calcium Carbonate; Citrates; Citric Acid; Delayed-Action Preparations; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride | 1991 |
Fluoride treatment in osteoporosis.
Topics: Aged; Aged, 80 and over; Female; Fluorides; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal | 1991 |
Treatment of osteoporosis. What is the role of calcium?
Topics: Calcitonin; Calcium; Estrogen Replacement Therapy; Exercise Therapy; Female; Fluorides; Humans; Osteoporosis, Postmenopausal; Risk Factors | 1990 |
Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Topics: Aged; Bone Density; Calcium; Drug Therapy, Combination; Female; Fluorides; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Sodium Fluoride; Spinal Diseases | 1990 |
Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Calcium; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal; Spine; Time Factors | 1990 |
[The new concept of osteoporosis. Early diagnosis, prevention and therapy are possible today].
Topics: Calcitonin; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Spontaneous; Humans; Male; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone | 1990 |
Effect of fluoride on postmenopausal osteoporosis.
Topics: Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal | 1990 |
[Osteoporosis].
Topics: Calcitonin; Female; Fluorides; Humans; Middle Aged; Osteoporosis, Postmenopausal | 1990 |